AFT Pharma has major step forward in US

Feb 7, 2024 | Companies, Latest News

7.2.24 AFT Pharmaceuticals’ shares rose strongly on NZX today after the company announced Maxigesic IV®, its patented pain relief medicine, has been launched in the US by its licensee Hikma Pharmaceuticals. AFT traded 14c higher at $3.84. The launch of the medicine, under the brand Combogesic IV®, is the first patented, New Zealand developed medicine […]

You need an active membership to keep reading

either log in via the form below or click here to subscribe

If you have recently subscribed and selected to pay by bank transfer our admin team will activate your membership once payment has cleared

[adrotate banner="4"]

AFT Pharma has major step forward in US

You need an active membership to keep reading

either log in via the form below or click here to subscribe

Your Advertisement Here

Your Advertisement Here